Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 54: 1497-1503, 2008. First published July 17, 2008; 10.1373/clinchem.2007.102442
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2007.102442v1
54/9/1497    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, D.
Right arrow Articles by Schneider, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, D.
Right arrow Articles by Schneider, F.
(Clinical Chemistry. 2008;54:1497-1503.)
© 2008 American Association for Clinical Chemistry, Inc.

General Clinical Chemistry

Prognostic Value of Chromogranin A at Admission in Critically Ill Patients: A Cohort Study in a Medical Intensive Care Unit

Dan Zhang1,2,3,2, Thomas Lavaux1,4,2, Anne-Claire Voegeli4, Thierry Lavigne1,4, Vincent Castelain1,4, Nicolas Meyer4,5, Rémy Sapin4, Dominique Aunis2, Marie-Hélène Metz-Boutigue2,a and Francis Schneider1,4

1 Service de Réanimation Médicale, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; 2 INSERM, Physiopathologie du Système Nerveux, Strasbourg, France; 3 First Hospital, Chongqing University of Medical Science, Chongqing, China; 4 School of Medicine, Louis Pasteur University, Strasbourg, France; 5 Pôle de Santé Publique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

aAddress correspondence to this author at: INSERM, U 575, Physiopathologie du Système Nerveux, Strasbourg, France. Fax 0033 3 88 60 08 06; e-mail metz{at}neurochem.u-strasbg.fr.

Background: Risk assessments of patients should be based on objective variables, such as biological markers that can be measured routinely. The acute response to stress causes the release of catecholamines from the adrenal medulla accompanied by chromogranin A (CGA). To date, no study has evaluated the prognostic value of CGA in critically ill intensive care unit patients.

Methods: We conducted a prospective study of intensive care unit patients by measuring serum procalcitonin (PCT), C-reactive protein (CRP), and CGA at the time of admission. Univariate and multivariate analyses were performed to evaluate the ability of these biomarkers to predict mortality.

Results: In 120 consecutive patients, we found positive correlations between CGA and the following: CRP (r2 = 0.216; P = 0.02), PCT (r2 = 0.396; P < 0.001), Simplified Acute Physiologic Score II (SAPS II) (r2 = 0.438; P < 0.001), and the Logistic Organ Dysfunction System (LODS) score (r2 = 0.374; P < 0.001). Nonsurvivors had significantly higher CGA and PCT concentrations than survivors [median (interquartile range): 293.0 µg/L (163.5–699.5 µg/L) vs 86.0 µg/L (53.8–175.3 µg/L) for CGA, and 6.78 µg/L (2.39–22.92 µg/L) vs 0.54 µg/L (0.16–6.28 µg/L) for PCT; P < 0.001 for both comparisons]. In a multivariable linear regression analysis, creatinine (P < 0.001), age (P < 0.001), and SAPS II (P = 0.002) were the only significant independent variables predicting CGA concentration (r2 = 0.352). A multivariate Cox regression analysis identified 3 independent factors predicting death: log-normalized CGA concentration [hazard ratio (HR), 7.248; 95% confidence interval (CI), 3.004–17.487], SAPS II (HR, 1.046; 95% CI, 1.026–1.067), and cardiogenic shock (HR, 3.920; 95% CI, 1.731–8.880).

Conclusions: CGA is a strong and independent indicator of prognosis in critically ill nonsurgical patients.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.